What is Tempus AI, Inc. Class A Common Stock?
operates as a healthcare technology company in the United States.
TEM · Verdict
Solid reward · elevated risk
TEM stands out on volatility and growth, but watch the cash flow signal.
Based on 88% data coverage
TEM · Verdict
Top decile vs peers
Rev +58.3% CAGR · earnings -5.4%
-19% free-cash-flow margin
Current ratio 3.13
-19% net margin · -89% ROE
Model-based scoring. For information only — not financial advice.
operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 9.52B.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.